130768-85-3

Basic information

• Product Name: (E)-1-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one
• Synonyms: (E)-1-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one
• CAS NO: 130768-85-3
• Molecular Weight: 328.365
• Mol File: 130768-85-3.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: (E)-1-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-1-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one(130768-85-3)
• EPA Substance Registry System: (E)-1-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one(130768-85-3)

Safety Data

• Hazardous Substances Data: 130768-85-3(Hazardous Substances Data)

Upstream product

• 5703-21-9 3,4-dimethoxyphenylacetaldehyde 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 1131-62-0 1-(3,4-dimethoxyphenyl)ethanone 

Downstream Products

• 94685-52-6 2,4-bis(3,4-dimethoxyphenyl)-4-butyronitrilone 
• 106593-04-8 (E)-1,3-bis(3,4-dihydroxyphenyl)prop-2-en-1-one 
• 1537880-19-5 (R,E)-3-(1,3-bis(3,4-dimethoxyphenyl)allyl)pentane-2,4-dione 
• 1537879-94-9 (E)-1,3-bis(3,4-dimethoxyphenyl)prop-2-en-1-ol 
• 688743-12-6 C₂₆H₂₄N₂O₄ 
• 54785-17-0 2,3,8,9-tetramethoxy-4b,10b,11,12-tetrahydro-benzo[c]phenanthridine 
• 858798-43-3 N-[2-(3,4-dimethoxy-phenyl)-6,7-dimethoxy-1,2,3,4-tetrahydro-[1]naphthyl]-formamide 
• 19611-21-3 6,7-dimethoxy-2-(3,4-dimethoxyphenyl)-1-tetralone 
• 19611-19-9 2,4-bis-(3,4-dimethoxy-phenyl)-butyric acid 
• 94757-88-7 2,4-bis-(3,4-dimethoxy-phenyl)-4-oxo-butyric acid 
• 94577-55-6 2,4-bis-(3,4-dimethoxy-phenyl)-4-oxo-butyric acid amide 
• 100976-54-3 1,3-Bis(3',4'-dihydroxyphenyl)-propane 
• 104151-29-3 cis-3-(3,4-dimethoxyphenyl)-1-methyl-5,6-dimethoxyindane 
• 111222-54-9 3-(3,4-Dimethoxy-phenyl)-5,6-dimethoxy-1-methyl-1H-indene 

Relevant articles and documents

Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors

Presently, artemisinin-based combination therapy (ACT) is the first-line therapy of Plasmodium falciparum malaria. With the emergence of malaria parasites that are resistant to ACT, alternative antimalarial therapies are urgently needed. In line with this

Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity

This study describes the synthesis of a series of chalcones, including pyrazole and α,β-epoxide derivatives, and evaluation of their cell growth inhibitory activity in three human tumor cell lines, as well as their lipophilicity using liposomes as a biomi

Synthesis and biological evaluation of chalcone, dihydrochalcone, and 1,3-diarylpropane analogs as anti-inflammatory agents

Twenty-one chalcones were prepared via aldol condensation and subsequent reduction of these compound led to the corresponding dihydrochalcone and 1,3-diphenylpropane derivatives. The synthetic products were examined for their effects on NO inhibition in L